Cataract Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: July 17, 2023 Report Code: GDME1571EPD-ST

Select Item

Cataract Surgery Devices Pipeline Market Report Overvie

Cataract surgery is the removal of the natural lens of the eye that has developed an opacification and is then replacing it with an artificial intraocular lens to restore transparency.

The Cataract Surgery Devices pipeline market research report provides comprehensive information about the Cataract Surgery Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Phacoemulsification Equipment and Accessories

·       Ophthalmic Viscoelastic Devices (OVD)

·       Femtosecond Laser

·       Dispersive OVD
Key Territories ·       The US

·       Europe

·       China

·       Israel

·       Japan

·       India
Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       PMA

·       ICAC

·       Ninsho
Leading Companies ·       Advanced Refractive Technologies Inc

·       Alcon Inc

·       Altacor Ltd

·       Bausch & Lomb Inc

·       Carl Zeiss Meditec AG

·       Centricity Vision Inc

·       Cirle, Inc

·       ClearSight Innovations Limited

·       Dutch Ophthalmic Research Center International BV

·       Eye Care and Cure
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cataract Surgery Devices Pipeline Market by Segments

The key segments in the cataract surgery devices market are Phacoemulsification Equipment and Accessories, Ophthalmic Viscoelastic Devices (OVD), Femtosecond Laser, and Dispersive OVD. As of July 2023, Phacoemulsification Equipment and Accessories has the highest number of pipeline products.

Cataract Surgery Devices Pipeline Market Analysis by Segments, 2023 (%)

Cataract Surgery Devices Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the cataract surgery devices pipeline market, download a free report sample

Cataract Surgery Devices Pipeline Market Segmentation by Territories

Some of the key territories in the cataract surgery devices market are the US, Europe, China, Israel, Japan, and India. As of July 2023, the US has the highest number of pipeline products.

Cataract Surgery Devices Pipeline Market Analysis by Territories, 2023 (%)

Cataract Surgery Devices Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the cataract surgery devices pipeline market, download a free report sample

Cataract Surgery Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the cataract surgery devices pipeline market are 510(k), CE, NMPA, PMA, ICAC, and Ninsho. As of July 2023, 510(k) is the most followed pathway for pipeline products in the market.

Cataract Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Cataract Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the cataract surgery devices pipeline market, download a free report sample

Cataract Surgery Devices Pipeline Market – Competitive Landscape

Some of the key companies in the cataract surgery devices pipeline market are Advanced Refractive Technologies Inc, Alcon Inc, Altacor Ltd, Bausch & Lomb Inc, Carl Zeiss Meditec AG, Centricity Vision Inc, Cirle, Inc, ClearSight Innovations Limited, Dutch Ophthalmic Research Center International BV, and Eye Care and Cure.

Advanced Refractive Technologies Inc: The company designs, develops, manufactures, and markets ophthalmic devices and pharmaceutical agents for the ophthalmology market. Its products are used in the therapeutic areas of cataract detection, cataract surgery, glaucoma therapy, and age-related macular degeneration. ART is headquartered in San Clemente, California, the US.

Alcon Inc: The company is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables, and surgical equipment. The company’s products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases, and refractive errors. Alcon is headquartered in Geneva, Switzerland.

Leading Cataract Surgery Devices Companies, 2023

Leading Cataract Surgery Devices Companies, 2023

For more company insights into the cataract surgery devices pipeline market, download a free report sample

Segments Covered in the Report

Cataract Surgery Devices Pipeline Market Segments Outlook

  • Phacoemulsification Equipment and Accessories
  • Ophthalmic Viscoelastic Devices (OVD)
  • Femtosecond Laser
  • Dispersive OVD

Cataract Surgery Devices Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Israel
  • Japan
  • India

Cataract Surgery Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • PMA
  • ICAC
  • Ninsho

Scope

This report provides:

  • Extensive coverage of the Cataract Surgery Devices under development.

  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.

  • Reviews of the major players involved in the development of Cataract Surgery Devices and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of Cataract Surgery Devices under development

  • Develop market-entry and market-expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Advanced Refractive Technologies Inc
Alcon Inc
Altacor Ltd
Bausch & Lomb Inc
Carl Zeiss Meditec AG
Centricity Vision Inc
Cirle, Inc
ClearSight Innovations Limited
Dutch Ophthalmic Research Center International BV
Eye Care and Cure
ForSight Robotics Ltd
Hebrew University of Jerusalem
International BioMedical Devices Inc
Medicontur Medical Engineering Ltd
OptoLight Vision Technology
Paradigm Medical Industries, Inc. (Inactive)
Seikagaku Corp
Shanghai Haohai Biological Technology Co Ltd
STAAR Surgical Company
Tear Diagno LLC (Inactive)
Tupai (Beijing) Medical Technology Co Ltd
University of California Los Angeles
University of Colorado Anschutz Medical Campus
University of Florida
University of Michigan
University of Texas Medical Branch at Galveston
VSY Biotechnology BV
Wake Forest Baptist Medical Center

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 9

2 Introduction 10

2.1 Cataract Surgery Devices Overview 10

3 Products under Development 11

3.1 Cataract Surgery Devices – Pipeline Products by Stage of Development 11

3.2 Cataract Surgery Devices – Pipeline Products by Segment 12

3.3 Cataract Surgery Devices – Pipeline Products by Territory 13

3.4 Cataract Surgery Devices – Pipeline Products by Regulatory Path 14

3.5 Cataract Surgery Devices – Pipeline Products by Estimated Approval Date 15

3.6 Cataract Surgery Devices – Ongoing Clinical Trials 16

4 Cataract Surgery Devices – Pipeline Products under Development by Companies 17

4.1 Cataract Surgery Devices Companies – Pipeline Products by Stage of Development 17

4.2 Cataract Surgery Devices – Pipeline Products by Stage of Development 19

5 Cataract Surgery Devices Companies and Product Overview 21

5.1 Advanced Refractive Technologies Inc Company Overview 21

5.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Alcon Inc Company Overview 22

5.2.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Altacor Ltd Company Overview 27

5.3.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Bausch & Lomb Inc Company Overview 28

5.4.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Carl Zeiss Meditec AG Company Overview 34

5.5.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 34

5.6 Centricity Vision Inc Company Overview 35

5.6.1 Centricity Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.7 Cirle, Inc Company Overview 36

5.7.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 ClearSight Innovations Limited Company Overview 37

5.8.1 ClearSight Innovations Limited Pipeline Products & Ongoing Clinical Trials Overview 37

5.9 Dutch Ophthalmic Research Center International BV Company Overview 38

5.9.1 Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 38

5.10 Eye Care and Cure Company Overview 39

5.10.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 39

5.11 ForSight Robotics Ltd Company Overview 40

5.11.1 ForSight Robotics Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.12 Hebrew University of Jerusalem Company Overview 41

5.12.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 41

5.13 International BioMedical Devices Inc Company Overview 42

5.13.1 International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.14 Medicontur Medical Engineering Ltd Company Overview 43

5.14.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.15 OptoLight Vision Technology Company Overview 44

5.15.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 Paradigm Medical Industries, Inc. (Inactive) Company Overview 45

5.16.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 Seikagaku Corp Company Overview 46

5.17.1 Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview 46

5.18 Shanghai Haohai Biological Technology Co Ltd Company Overview 49

5.18.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 STAAR Surgical Company Company Overview 50

5.19.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 50

5.20 Tear Diagno LLC (Inactive) Company Overview 51

5.20.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51

5.21 Tupai (Beijing) Medical Technology Co Ltd Company Overview 52

5.21.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.22 University of California Los Angeles Company Overview 53

5.22.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 53

5.23 University of Colorado Anschutz Medical Campus Company Overview 54

5.23.1 University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 54

5.24 University of Florida Company Overview 55

5.24.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 55

5.25 University of Michigan Company Overview 56

5.25.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 56

5.26 University of Texas Medical Branch at Galveston Company Overview 57

5.26.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 57

5.27 VSY Biotechnology BV Company Overview 58

5.27.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 58

5.28 Wake Forest Baptist Medical Center Company Overview 59

5.28.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 59

6 Cataract Surgery Devices- Recent Developments 60

6.1 May 10, 2023: LENSAR to report Q1 2023 financial results on Monday, May 15, 2023 60

6.2 May 08, 2023: Ocular Therapeutix provides first quarter 2023 financial results and corporate update 60

6.3 Apr 26, 2023: Canon Announces Consolidated Results For The First Quarter Ended March 31, 2023 62

6.4 Apr 19, 2023: Anika to issue first quarter 2023 financial results on Tuesday, may 9, 2023 63

6.5 Mar 29, 2023: STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer 63

6.6 Mar 29, 2023: Canon Publishes Annual Report for the Year Ended December 31, 2022 64

6.7 Mar 09, 2023: LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 65

6.8 Mar 06, 2023: Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results 66

6.9 Feb 21, 2023: Ocular Therapeutix To Report Fourth Quarter and Year-End 2022 Financial Results 67

6.10 Feb 21, 2023: Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023 68

6.11 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23 68

6.12 Feb 01, 2023: Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22 69

6.13 Jan 30, 2023: Canon Announces Consolidated Results For The Fourth Quarter And The Fiscal Year Ended December 31, 2022 69

6.14 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22 70

6.15 Jan 09, 2023: STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022 70

6.16 Jan 08, 2023: RxSight Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results 71

6.17 Nov 08, 2022: Anika Reports Third Quarter Fiscal 2022 Financial Results 72

6.18 Oct 26, 2022: Canon Announces Consolidated Results For The Third Quarter And The Nine Months Ended September 30, 2022 74

6.19 Oct 25, 2022: Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 74

6.20 Oct 24, 2022: Ocular Therapeutix To Report Third Quarter 2022 Financial Results 74

6.21 Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2 75

6.22 Sep 28, 2022: Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting 75

6.23 Sep 28, 2022: Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations 75

6.24 Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting 76

6.25 Sep 22, 2022: Ocular Therapeutix To Present Data at the American Academy of Ophthalmology 2022 Annual Meeting 78

6.26 Sep 15, 2022: BVI announces certification for its intraocular lens portfolio under the European Medical Device Regulation 80

6.27 Sep 12, 2022: Santen Announces Change of Representative Director of the Board (change in CEO) 80

6.28 Sep 07, 2022: Ocular Therapeutix to Present at the H.C. Wainwright 24th Annual Global Investment Conference 81

6.29 Aug 10, 2022: Ocular Therapeutix to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference 82

6.30 Aug 10, 2022: STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y 82

6.31 Aug 08, 2022: Ocular Therapeutix Reports Second Quarter 2022 Financial Results and Business Update 84

6.32 Aug 03, 2022: Anika Reports Second Quarter Fiscal 2022 Financial Results 86

6.33 Jul 27, 2022: Bausch Health Companies will Release Second-Quarter 2022 Financial Results on Aug. 9 89

6.34 Jul 25, 2022: Ocular Therapeutix to Report Second Quarter 2022 Financial Results 90

6.35 Jul 18, 2022: Carl Zeiss Meditec and Precise Bio announce partnership in the development and commercialization of tissue-based implants for ophthalmology 90

6.36 Jul 12, 2022: Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 91

7 Appendix 92

7.1 Methodology 92

7.2 About GlobalData 95

7.3 Contact Us 95

7.4 Disclaimer 95

Table

Cataract Surgery Devices – Pipeline Products by Stage of Development 11

Cataract Surgery Devices – Pipeline Products by Segment 12

Cataract Surgery Devices – Pipeline Products by Territory 13

Cataract Surgery Devices – Pipeline Products by Regulatory Path 14

Cataract Surgery Devices – Pipeline Products by Estimated Approval Date 15

Cataract Surgery Devices – Ongoing Clinical Trials 16

Cataract Surgery Devices Companies – Pipeline Products by Stage of Development 17

Cataract Surgery Devices – Pipeline Products by Stage of Development 19

Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Accupulse Cataract Emulsifier – Product Status 21

Accupulse Cataract Emulsifier – Product Description 21

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Next-Gen Phaco-Vit – Product Status 22

Next-Gen Phaco-Vit – Product Description 22

Next-Generation Phaco Vit-Ret Console – Product Status 23

Next-Generation Phaco Vit-Ret Console – Product Description 23

Novel Delivery System – Product Status 23

Novel Delivery System – Product Description 23

WaveLight UV-Femtosecond Laser System (Model-1026) – Product Status 24

WaveLight UV-Femtosecond Laser System (Model-1026) – Product Description 24

Alcon Inc – Ongoing Clinical Trials Overview 25

WaveLight UV-Femtosecond Laser System (Model-1026) – Clinical Investigation of the Wavelight UV Femtosecond Laser for Corneal Flap Creation 26

WaveLight UV-Femtosecond Laser System (Model-1026) – UV Femtosecond Laser Assisted Lenticule Extraction Sphere Nomogram Study 26

Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

SOLO – Product Status 27

SOLO – Product Description 27

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 28

BLS – 001: Cataract – Product Status 28

BLS – 001: Cataract – Product Description 28

BLS – 002: Cataract – Product Status 29

BLS – 002: Cataract – Product Description 29

BLS – 003: Cataract – Product Status 29

BLS – 003: Cataract – Product Description 29

BLS – 004: Cataract – Product Status 30

BLS – 004: Cataract – Product Description 30

BLS – 006: Cataract – Product Status 30

BLS – 006: Cataract – Product Description 30

BLS – 007: Cataract – Product Status 31

BLS – 007: Cataract – Product Description 31

BLS – 008: Cataract – Product Status 31

BLS – 008: Cataract – Product Description 31

BLS – 010: Cataract – Product Status 32

BLS – 010: Cataract – Product Description 32

BLS – 011: Cataract – Product Status 32

BLS – 011: Cataract – Product Description 32

BLS – 015: Cataract – Product Status 33

BLS – 015: Cataract – Product Description 33

BLS – 016: Cataract – Product Status 33

BLS – 016: Cataract – Product Description 33

Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 34

Cataract Surgery Device – Product Status 34

Cataract Surgery Device – Product Description 34

Centricity Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Zepto-PEDS – Product Status 35

Zepto-PEDS – Product Description 35

Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 36

SNS 200 – Product Status 36

SNS 200 – Product Description 36

ClearSight Innovations Limited Pipeline Products & Ongoing Clinical Trials Overview 37

Mirricon – Product Status 37

Mirricon – Product Description 37

Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 38

EVA Phaco-Vitrectomy System – Product Status 38

EVA Phaco-Vitrectomy System – Product Description 38

Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 39

Ophthalmic Device – Cataract Surgery – Product Status 39

Ophthalmic Device – Cataract Surgery – Product Description 39

ForSight Robotics Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Surgical Robotic System – Product Status 40

Surgical Robotic System – Product Description 40

Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 41

Ophthalmic Viscoelastic Device – Product Status 41

Ophthalmic Viscoelastic Device – Product Description 41

International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 42

ApertureRx Precision Capsulotomy System – Product Status 42

ApertureRx Precision Capsulotomy System – Product Description 42

Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

Pre-Filled Injection System – Product Status 43

Pre-Filled Injection System – Product Description 43

OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 44

Lipshitz Macular Implant – Diabetic Maculopathy – Product Status 44

Lipshitz Macular Implant – Diabetic Maculopathy – Product Description 44

Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

Photon Laser System – Product Status 45

Photon Laser System – Product Description 45

Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview 46

SI-614 – Dry Eye Disease – Product Status 46

SI-614 – Dry Eye Disease – Product Description 46

Seikagaku Corp – Ongoing Clinical Trials Overview 47

SI-614 – Dry Eye Disease – A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of SI-614 in Patients with Dry Eyes 48

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

QST Gel – OVD – Product Status 49

QST Gel – OVD – Product Description 49

STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 50

Preloaded Injector System – Collamer IOL – Product Status 50

Preloaded Injector System – Collamer IOL – Product Description 50

Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51

Cataract Surgical Device – Product Status 51

Cataract Surgical Device – Product Description 51

Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Full Femtosecond Laser – Product Status 52

Full Femtosecond Laser – Product Description 52

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 53

Intraocular Robotic Interventional Surgical System (IRISS) – Product Status 53

Intraocular Robotic Interventional Surgical System (IRISS) – Product Description 53

University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 54

Intraocular Prosthetic With Foot Plates – Product Status 54

Intraocular Prosthetic With Foot Plates – Product Description 54

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 55

Intraocular Lens Removal Device – Product Status 55

Intraocular Lens Removal Device – Product Description 55

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 56

Surgical Knife – Product Status 56

Surgical Knife – Product Description 56

University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 57

Ocular Surgery Device – Product Status 57

Ocular Surgery Device – Product Description 57

VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 58

Protectolan 3% – Product Status 58

Protectolan 3% – Product Description 58

Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 59

Aspiration And Irrigation Handpiece Tip – Product Status 59

Aspiration And Irrigation Handpiece Tip – Product Description 59

Glossary 94

Figures

Cataract Surgery Devices – Pipeline Products by Stage of Development 10

Cataract Surgery Devices – Pipeline Products by Segment 11

Cataract Surgery Devices – Pipeline Products by Territory 12

Cataract Surgery Devices – Pipeline Products by Regulatory Path 13

Cataract Surgery Devices – Pipeline Products by Estimated Approval Date 14

Cataract Surgery Devices – Ongoing Clinical Trials 15

Frequently asked questions

Cataract Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cataract Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cataract Surgery Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cataract Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Cataract Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more